This week Legal Director Yifei Xu and Operations Officer Jacob Bragg met with Biopharmaceutical lead Dr Kirsten Heimann and project coordinator Adele Mastroyannis. 

The meeting discussed the ongoing collaboration between Wonderful Capital Biotechnology group and the Marine Bioproducts Cooperative Research Centre. The project on the Biorefinery production of brown seaweed polyphenols and their applications in skin health was primarily discussed. Highlights of the meeting were that tremendous progress has been made. And Yifei Xu answered questions on the long-term goals of the research and the direction that the study needs to head in. 

Overall, Wonderful Capital Biotechnology Group continues its pursuit of ground-breaking research with the assistance of world-class researchers.